Aarthi R Gobinath
Overview
Explore the profile of Aarthi R Gobinath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qiu W, Gobinath A, Wen Y, Austin J, Galea L
J Neuroendocrinol
. 2019 Sep;
31(10):e12787.
PMID: 31478270
Folate is an important regulator of hippocampal neurogenesis, and folic acid is needed prenatally to reduce the risk of neural tube defects. Both high levels of folic acid and low...
2.
Eid R, Gobinath A, Galea L
Prog Neurobiol
. 2019 Feb;
176:86-102.
PMID: 30721749
Depression represents a global mental health concern, and disproportionally affects women as they are twice more likely to be diagnosed than men. In this review, we provide a summary of...
3.
Gobinath A, Wong S, Chow C, Lieblich S, Barr A, Galea L
Psychoneuroendocrinology
. 2018 Mar;
91:186-197.
PMID: 29579632
Treating postpartum depression (PPD) with pharmacological antidepressants like fluoxetine (FLX) is complicated because these drugs can remain active in breast milk and potentially affect infant development. Alternatively, non-pharmacological treatments such...
4.
Gobinath A, Richardson R, Chow C, Workman J, Lieblich S, Barr A, et al.
Neuropharmacology
. 2017 Oct;
128:106-118.
PMID: 28964735
Postpartum depression affects approximately 15% of mothers. Unfortunately, treatment options for postpartum depression are limited. Pharmacological antidepressants such as fluoxetine (FLX) can be controversial due to inconclusive evidence of efficacy...
5.
Gobinath A, Workman J, Chow C, Lieblich S, Galea L
Biol Sex Differ
. 2017 Jun;
8:20.
PMID: 28580124
Background: Postpartum depression affects approximately 15% of mothers and represents a form of early life adversity for developing offspring. Postpartum depression can be treated with prescription antidepressants like fluoxetine (FLX)....
6.
Gobinath A, Choleris E, Galea L
J Neurosci Res
. 2016 Nov;
95(1-2):50-64.
PMID: 27870452
Sex differences exist in the vulnerability, incidence, manifestation, and treatment of numerous neurological and psychiatric diseases. Despite this observation prominent in the literature, little consideration has been given to possible...
7.
Workman J, Gobinath A, Kitay N, Chow C, Brummelte S, Galea L
Neuropharmacology
. 2016 Jan;
105:443-453.
PMID: 26808316
The postpartum confers considerable risk for developing depression. Depressed patients have elevated cortisol concentrations and impaired hypothalamic-pituitary-adrenal (HPA) axis negative feedback. Chronic stress or corticosterone (CORT) induces a depressive-like phenotype...
8.
Gobinath A, Workman J, Chow C, Lieblich S, Galea L
Neuropharmacology
. 2015 Sep;
101:165-78.
PMID: 26391064
Postpartum depression (PPD) affects approximately 15% of mothers, disrupts maternal care, and can represent a form of early life adversity for the developing offspring. Intriguingly, male and female offspring are...
9.
Gobinath A, Mahmoud R, Galea L
Front Neurosci
. 2015 Jan;
8:420.
PMID: 25610363
Sex differences exist in vulnerability, symptoms, and treatment of many neuropsychiatric disorders. In this review, we discuss both preclinical and clinical research that investigates how sex influences depression endophenotypes at...